162 results on '"Kristensen, Gunnar B"'
Search Results
2. Impact of molecular profile on prognosis and relapse pattern in low and intermediate risk endometrial cancer
3. Long-term oncological outcomes and recurrence patterns in early-stage cervical cancer treated with minimally invasive versus abdominal radical hysterectomy: The Norwegian Radium Hospital experience
4. DCE-MRI–Derived Measures of Tumor Hypoxia and Interstitial Fluid Pressure Predict Outcomes in Cervical Carcinoma
5. DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses
6. Neoadjuvant Chemotherapy Versus Debulking Surgery in Advanced Tubo-Ovarian Cancers: Pooled Analysis of Individual Patient Data From the EORTC 55971 and CHORUS Trials
7. Peritumoral interstitial fluid flow velocity predicts survival in cervical carcinoma
8. Gene expression signatures of primary and metastatic uterine leiomyosarcoma
9. Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy
10. Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome
11. CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data.
12. Dynamic Contrast-Enhanced MRI of Cervical Cancers: Temporal Percentile Screening of Contrast Enhancement Identifies Parameters for Prediction of Chemoradioresistance
13. Late Effects After Radiotherapy for Locally Advanced Cervical Cancer: Comparison of Two Brachytherapy Schedules and Effect of Dose Delivered Weekly
14. Neoadjuvant chemotherapy of primary surgery in stage IIIC or IV ovarian cancer
15. Prognostic significance of dysadherin expression in cervical squamous cell carcinoma
16. The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions
17. Expression of the 67 kDa laminin receptor and the α6 integrin subunit in serous ovarian carcinoma
18. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma
19. Identification of eight candidate target genes of the recurrent 3p12–p14 loss in cervical cancer by integrative genomic profiling
20. Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions
21. miR-200a/b/-429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer.
22. Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma – diagnostic and prognostic implications
23. Genomic imbalances in endometrial adenocarcinomas – Comparison of DNA ploidy, karyotyping and comparative genomic hybridization
24. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients
25. Epithelial ovarian carcinoma
26. Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinoma
27. E-cadherin and catenins in early squamous cervical carcinoma
28. Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma
29. Cyclins and proliferation markers in early squamous cervical carcinoma
30. Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis
31. Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas
32. Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer
33. Expression of Cell Cycle Proteins in Ovarian Carcinoma Cells in Serous Effusions—Biological and Prognostic Implications
34. Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients
35. Effects of Paclitaxel on CA-125 Serum Levels in Ovarian Cancer Patients
36. Tumor Size, Depth of Invasion, and Grading of the Invasive Tumor Front Are the Main Prognostic Factors in Early Squamous Cell Cervical Carcinoma
37. Aberrant Expression of the Cell Cycle Associated Proteins TP53, MDM2, p21, p27, cdk4, Cyclin D1, RB, and EGFR in Cervical Carcinomas
38. Pharmacokinetic analysis of DCE-MRI data of locally advanced cervical carcinoma with the Brix model.
39. A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway.
40. Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer.
41. Systematic analysis of circulating soluble angiogenesis-associated proteins in ICON7 identifies Tie2 as a biomarker of vascular progression on bevacizumab.
42. Identification and Validation of Reference Genes for RT-qPCR Studies of Hypoxia in Squamous Cervical Cancer Patients.
43. Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer.
44. Entropy-based adaptive nuclear texture features are independent prognostic markers in a total population of uterine sarcomas.
45. Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO).
46. Long-Term Outcomes After Pelvic Radiation for Early-Stage Endometrial Cancer.
47. High Levels of Genomic Aberrations in Serous Ovarian Cancers Are Associated with Better Survival.
48. Diagnosis and treatment of sarcoma of the uterus. A review.
49. The prognostic value of adaptive nuclear texture features from patient gray level entropy matrices in early stage ovarian cancer.
50. Pharmacokinetic analysis and k-means clustering of DCEMR images for radiotherapy outcome prediction of advanced cervical cancers.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.